The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter observational study of nanoliposomal irinotecan and fluorouracil/leucovorin in patients with unresectable or recurrent pancreatic cancer (NAPOLEON-2): Final retrospective results.
 
Takashi Imajima
No Relationships to Disclose
 
Tsuyoshi Shirakawa
No Relationships to Disclose
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Taiga Otsuka
No Relationships to Disclose
 
Taro Shibuki
No Relationships to Disclose
 
Junichi Nakazawa
No Relationships to Disclose
 
Shiho Arima
No Relationships to Disclose
 
Keisuke Miwa
No Relationships to Disclose
 
Futa Koga
No Relationships to Disclose
 
Yoshihito Kubotsu
No Relationships to Disclose
 
Yujiro Ueda
No Relationships to Disclose
 
Ayumu Hosokawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Shigeyuki Takeshita
No Relationships to Disclose
 
Hozumi Shimokawa
No Relationships to Disclose
 
Azusa Komori
No Relationships to Disclose
 
Hisanobu Oda
No Relationships to Disclose
 
Tatsunori Sakai
No Relationships to Disclose
 
Shuji Arita
No Relationships to Disclose
 
Toshihiko Mizuta
No Relationships to Disclose
 
Kenji Mitsugi
No Relationships to Disclose